Published in Clin Endocrinol (Oxf) on March 01, 1979
Chronic heart failure in Australian general practice. The Cardiac Awareness Survey and Evaluation (CASE) Study. Med J Aust (2001) 2.71
Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation (1998) 1.87
Occupational exposure to the human immunodeficiency virus and other blood-borne pathogens. A six-year prospective study. Med J Aust (1993) 1.81
Developmental expression of ACE2 in the SHR kidney: a role in hypertension? Kidney Int (2006) 1.68
Evidence from cross circulation studies for a humoral mechanism in the natriuresis of saline loading. Proc Soc Exp Biol Med (1966) 1.61
Cross-circulation experiments on the mechanism of the natriuresis during saline loading in the dog. Circ Res (1967) 1.55
Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch Gen Psychiatry (1990) 1.54
Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase. Br Heart J (1989) 1.39
Comparison of angiotensin converting enzyme inhibitors captopril and MK421-diacid in guinea pig atria. Eur J Pharmacol (1982) 1.35
Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension. Lancet (1979) 1.34
Angiotensin receptors: distribution, signalling and function. Clin Sci (Lond) (2001) 1.27
Safety and side-effects of buprenorphine in the clinical management of heroin addiction. Drug Alcohol Depend (1990) 1.24
Atrial natriuretic peptide in chronic heart failure in the rat: a correlation with ventricular dysfunction. Circ Res (1986) 1.23
Reduced osmotic thirst in healthy elderly men. Am J Physiol (1991) 1.20
Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. Am J Pathol (1999) 1.19
Angiotensin-converting enzyme inhibitors in the treatment of hypertension. Drugs (1984) 1.15
Swapping health care systems. Whose grass is really greener? JAMA (1996) 1.15
Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal. Clin Pharmacol Ther (1990) 1.14
Quality assessment program for genotypic antiretroviral testing improves detection of drug resistance mutations. J Clin Microbiol (2003) 1.04
Isolation of renin granules from rat kidney cortex and evidence for an inactive form of renin (prorenin) in granules and plasma. Endocrinology (1976) 1.03
Radioimmunoassay for plasma antidiuretic hormone. J Endocrinol (1972) 1.02
A comparison of chlorothiazide, chlorthalidone and cyclopenthiazide in the treatment of hypertension. Med J Aust (1973) 1.02
Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients. Clin Sci (Lond) (1981) 1.00
Renin substrate in granules from rat kidney cortex. Biochem J (1976) 0.99
Metabolism of angiotensin II in sodium depletion and hypertension in humans. Circ Res (1972) 0.99
Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension. Clin Exp Pharmacol Physiol Suppl (1982) 0.99
Psychological aspects of hysterectomy. A prospective study. Br J Psychiatry (1989) 0.99
Vasopressin in circulatory control and hypertension. J Hypertens (1985) 0.98
Enalapril (MK421) activation in man: importance of liver status. Br J Clin Pharmacol (1985) 0.98
Contribution of vasopressin to the maintenance of blood pressure during dehydration. Am J Physiol (1983) 0.97
Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands. Endocrinology (1990) 0.97
The relationship of plasma levels of pindolol in hypertensive patients to effects on blood pressure, plasma renin and plasma noradrenaline levels. Clin Exp Pharmacol Physiol (1975) 0.96
Neurohumoral responses to chronic myocardial infarction in rats. Circulation (1988) 0.95
Renin, angiotensin II, and adrenal corticosteroid relationships during sodium deprivation and angiotensin infusion in normotensive and hypertensive man. Circ Res (1972) 0.95
Inhibition of adenylate cyclase by angiotensin II in rat renal cortex. Endocrinology (1982) 0.95
HIV infection and international travel. Am Fam Physician (1987) 0.95
Adrenal suppression following extradural steroids. Anaesthesia (1983) 0.95
Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition. J Hypertens Suppl (1983) 0.94
Plasma renin levels and vascular complications in hypertension. Br Med J (1973) 0.94
Localization of endothelin receptors in rat kidney. Eur J Pharmacol (1989) 0.94
Acute renal haemodynamic and renin-angiotensin system responses to graded renal artery stenosis in the dog. J Physiol (1979) 0.94
Chronotropic effects of angiotensin I, angiotensin II, bradykinin and vasopressin in guinea pig atria. Eur J Pharmacol (1982) 0.92
Angiotensin converting enzyme inhibition in renovascular hypertension: frequency of reversible renal failure. Lancet (1984) 0.92
Treatment of hypertension with angiotensin converting enzyme inhibitors. Clin Exp Pharmacol Physiol Suppl (1982) 0.92
Excretion of oestrogens, pregnanediol and chorionic gonadotrophin in patients with hydatidiform mole. J Obstet Gynaecol Br Commonw (1970) 0.92
Use of captopril in the diagnosis of renal hypertension. Aust N Z J Med (1981) 0.91
Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels. Am J Cardiol (1982) 0.91
Vasopressin V1 and V2 receptors in diabetes mellitus. Am J Physiol (1994) 0.91
Mechanism of the age-related decrease of epinephrine-stimulated lipolysis in isolated rat adipocytes: beta-adrenergic receptor binding, adenylate cyclase activity, and cyclic AMP accumulation. J Lipid Res (1981) 0.90
A review of plasma renin measurements and their clinical significance. Aust N Z J Med (1971) 0.90
Increased cardiac angiotensin-converting enzyme in rats with chronic heart failure. Clin Exp Pharmacol Physiol (1990) 0.90
Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients. Clin Exp Pharmacol Physiol (1981) 0.90
Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension. Br J Clin Pharmacol (1984) 0.90
Decreased cardiac beta-adrenergic receptors in deoxycorticosterone-salt and renal hypertensive rats. Circ Res (1979) 0.90
Biological significance of renin angiotensin immunization. Circ Res (1970) 0.90
Immunoreactive arginine-vasopressin in Brattleboro rat ovary. Nature (1984) 0.89
Glucocorticoid insufficiency, achalasia, alacrima with autonomic motor neuropathy. Ann Intern Med (1987) 0.89
Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of Australia. Clin Exp Hypertens (1997) 0.89
Regeneration of beta-adrenergic receptors in senescent rats: a study using an irreversible binding antagonist. Proc Natl Acad Sci U S A (1982) 0.88
Localization of angiotensin converting enzyme in rat heart. Circ Res (1991) 0.88
Identification, distribution, and expression of angiotensin II receptors in the normal human prostate and benign prostatic hyperplasia. Endocrinology (2001) 0.88
Ectopic production of methionine enkephalin and beta-endorphin. Br Med J (1980) 0.88
Quality of human immunodeficiency virus viral load testing in Australia. J Clin Microbiol (2000) 0.88
Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies. Vox Sang (2001) 0.88
Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition. Kidney Int (1981) 0.88
Inhibition of adenylate cyclase in rat adrenal glomerulosa cells by angiotensin II. Endocrinology (1984) 0.88
Restoration of suppressed baroreflex sensitivity in rats with hereditary diabetes insipidus (Brattleboro rats) by arginine-vasopressin and DDAVP. Circ Res (1983) 0.87
Relation of plasma renin to sodium balance and arterial pressure in experimental renal hypertension. Circ Res (1966) 0.87
Increased sensitivity to epinephrine stimulated lipolysis during starvation: tighter coupling of the adenylate cyclase complex. Biochem Biophys Res Commun (1981) 0.87
Controlled trial of enalapril in congestive cardiac failure. Br Heart J (1985) 0.87
Effects of deoxycorticosterone on plasma renin acitivity in conscious dogs. Am J Physiol (1969) 0.87
Emergency treatment of severe hypertension with intravenous labetalol. Med J Aust (1978) 0.87
Role of vasopressin in hypertension: studies using the Brattleboro rat. Am J Physiol (1982) 0.87
Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy. Diabetologia (2003) 0.86
Hypogonadism in patients treated with intrathecal morphine. Clin J Pain (2000) 0.86
In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan. Am J Hypertens (2000) 0.86
The contribution of vasopressin and angiotensin to the maintenance of blood pressure after autonomic blockade. Hypertension (1985) 0.86
Acute angiotensin II-mediated restoration of distal renal artery pressure in renal artery stenosis and its relationship to the development of sustained one-kidney hypertension in conscious dogs. Hypertension (1980) 0.86
Lisinopril pharmacokinetics in chronic renal failure. Br J Clin Pharmacol (1988) 0.85
Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia. J Pathol (2001) 0.85
Identification of angiotensin converting enzyme 2 in the rodent retina. Curr Eye Res (2004) 0.85
ACTH LPH and related peptides in the ectopic ACTH syndrome. Clin Endocrinol (Oxf) (1980) 0.85
Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade. Am J Hypertens (1996) 0.84
Localization and characterization of endothelin receptor binding sites in the rat brain visualized by in vitro autoradiography. Neuroscience (1991) 0.84
Tissue-specific control of glandular kallikreins. Am J Physiol (1984) 0.84
Role of vasopressin in cardiovascular homeostasis and hypertension. Clin Sci (Lond) (1981) 0.84
Changes in tissue alpha- and beta-adrenergic receptors in renal hypertension in the rat. Hypertension (1980) 0.84
Adrenergic ligand liposolubility in membranes. Direct assessment in a beta-adrenergic binding system. Mol Pharmacol (1982) 0.84
IFFS expert group report on the Whittemore study related to the risk of ovarian cancer associated with the use of infertility agents. Hum Reprod (1993) 0.84
Plasma atrial natriuretic peptide: concentrations and circulating forms in normal man and patients with chronic renal failure. Clin Exp Pharmacol Physiol (1987) 0.84
Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension. J Hypertens (1984) 0.84
Salt blocks the renal benefits of ramipril in diabetic hypertensive rats. Hypertension (1991) 0.84
Vasopressin receptor antagonism--a therapeutic option in heart failure and hypertension. Exp Physiol (2000) 0.83
Hormonal responses to angiotensin blockade. Comparison between receptor antagonism and converting enzyme inhibition. Circ Res (1980) 0.83
Humoral factors in the regulation of renal sodium excretion. Fed Proc (1967) 0.83
Multisite evaluation of four anti-HIV-1/HIV-2 enzyme immunoassays. Australian HIV Test Evaluation Group. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.83
Localization of vasopressin binding sites in rat brain by in vitro autoradiography using a radioiodinated V1 receptor antagonist. Neuroscience (1988) 0.83
Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat. Hypertension (1994) 0.83